Skip to contentE
Electromedical Technologies, Inc
E
EMEDElectromedical Technologies, Inc Q3 2022 · 10-Q
Revenue$279.55K$279.55K−7.2% vs Q3 2021 Net Income-$957.95K-$957.95KN/M vs Q3 2021 EPS Diluted-$0.01-$0.01N/M vs Q3 2021 Gross Profit$221,543−5.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Electromedical Technologies, Inc · CIK 1715819 · Engraved from SEC EDGAR
Operating Cash Flowderived-$324,473N/M Margins · derivedGross margin79.2%+1.4 pt vs Q3 2021
Operating margin-120.7%−47.4 pt vs Q3 2021
Net margin-342.7%+753.0 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end